Medpace Holdings, Inc. officer Susan E. Burwig filed a Form 144 notice on October 27, 2026, disclosing a proposed sale of 3,940 shares of Medpace common stock on NASDAQ through Fidelity Brokerage Services LLC.

Key Highlights

  • Proposed sale: 3,940 shares of Medpace Holdings common stock with an aggregate market value of $2,667,380.00.
  • Seller: Susan E. Burwig, identified as an officer of Medpace Holdings, Inc. (NASDAQ:MEDP).
  • Acquisition source: The 3,940 shares were acquired on September 26, 2025, via a stock option exercise from the issuer, with cash payment on the same date.
  • Approximate sale date: October 27, 2026, through Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.
  • Shares outstanding: 27,971,686 shares of common stock outstanding at the time of the filing.
  • Prior sales in past 3 months: Burwig sold 7,500 shares on July 28, 2026, for gross proceeds of $4,500,000.00, and 16,060 shares on October 26, 2026, for gross proceeds of $10,872,620.00.

Burwig's Proposed Share Sale and Recent Transaction History at Medpace Holdings

According to the Form 144 filing, Susan E. Burwig, an officer of Medpace Holdings, Inc., intends to sell 3,940 shares of the company's common stock. The filing lists the aggregate market value of the proposed sale at $2,667,380.00. The broker facilitating the transaction is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The approximate date of sale is listed as October 27, 2026, on NASDAQ.

The filing discloses that the 3,940 shares were acquired on September 26, 2025, through a stock option exercise from the issuer, with payment made in cash on the same date. At the time of the filing, Medpace Holdings had 27,971,686 shares of common stock outstanding, according to the notice.

The filing also sets out Burwig's sales activity during the preceding three months. According to the disclosure, she sold 7,500 shares on July 28, 2026, generating gross proceeds of $4,500,000.00, and sold an additional 16,060 shares on October 26, 2026, generating gross proceeds of $10,872,620.00. The notice was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Susan Burwig, and dated October 27, 2026.

What Was Disclosed

Medpace Holdings officer Susan E. Burwig filed a Rule 144 notice proposing to sell 3,940 shares of company common stock valued at $2,667,380.00, acquired via stock option exercise in September 2025, with Fidelity Brokerage Services LLC as broker on NASDAQ.